Latest DEF 14A proxy statements
NYSE
Quanex Building Products Corporation announces its 2026 Annual Meeting agenda, including director elections, an advisory vote on executive compensation, and the ratification of KPMG LLP as its new independent auditor, replacing Grant Thornton LLP due to a material weakness in internal controls.
AMEX
Gencor Industries announces its 2026 Annual Meeting of Stockholders to elect directors, ratify a new auditor, and hold an advisory vote on executive compensation.
NASDAQ
Hurco Companies, Inc. announced its 2026 Annual Meeting agenda, including director elections, an advisory vote on executive compensation, and the ratification of its independent auditor, alongside disclosures of recent financial performance and governance updates.
NYSE
Semrush Holdings, Inc. filed additional proxy materials addressing three lawsuits challenging its proposed acquisition by Adobe Inc. and providing supplemental disclosures.
NASDAQ
Churchill Capital Corp IX has postponed its extraordinary general meeting to vote on the proposed business combination with Plus Automation, Inc. from February 3, 2026, to February 11, 2026.
NASDAQ
Aethlon Medical, Inc. announced amendments to its Pre-Funded Warrants, making them immediately exercisable, while still seeking shareholder approval for Nasdaq compliance.
IROQ
If Bancorp, INCIF Bancorp, Inc. is providing supplemental disclosures to its merger proxy statement with ServBanc Holdco, Inc. following shareholder lawsuits alleging misleading information, while denying any wrongdoing.
NASDAQ
FingerMotion, Inc. announced its upcoming Annual Meeting of Stockholders on February 26, 2026, to elect directors, ratify auditors, and vote on executive compensation.
NYSE
FICO
Fair Isaac CORPFair Isaac Corporation's 2026 proxy statement outlines proposals for director elections, executive compensation, auditor ratification, and key corporate charter amendments, alongside highlights of record fiscal 2025 financial performance.
NASDAQ
MEIP
Mei Pharma, INCLite Strategy, Inc. announced a supplement to its proxy statement, confirming Board member Joshua Riezman's independence, increasing the total independent directors to four out of six.
NASDAQ
PLUG
Plug Power INCPlug Power is calling on stockholders to vote in favor of critical proposals at its upcoming Special Meeting to ensure financial flexibility and support long-term growth.
AMEX
Eaton Vance California Municipal Income Trust and Eaton Vance Municipal Income Trust will hold their Annual Meeting on March 11, 2026, to elect three Class III Trustees.
NYSE
Eaton Vance California Municipal Income Trust and Eaton Vance Municipal Income Trust will hold their Annual Meeting on March 11, 2026, to elect three Class III Trustees.
NYSE
Eaton Vance Floating-Rate Income Trust announces its Annual Meeting of Shareholders on March 11, 2026, primarily for the election of three Class I Trustees.
NASDAQ
Construction Partners, Inc. reports exceeding fiscal 2025 financial and strategic goals, driven by key acquisitions and strong performance, while setting a new target to double revenue by 2030.
NYSE
CBT
Cabot CORPCabot Corporation announces its 2026 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation, and auditor ratification.
NYSE
CBT
Cabot CORPCabot Corporation announces its 2026 Annual Meeting of Stockholders to be held virtually on March 12, 2026, focusing on director elections, executive compensation advisory vote, and auditor ratification.
THAR
Tharimmune, INCTharimmune, Inc. issued a supplement to its proxy statement clarifying the independent status of two director nominees for its upcoming Special Meeting of Stockholders.
NASDAQ
Tevogen Bio Holdings Inc. calls a special meeting to vote on a reverse stock split to maintain Nasdaq listing and a significant increase in its equity incentive plan shares.
Klotho Neurosciences, Inc. will hold a Special Meeting to vote on a reverse stock split to meet Nasdaq listing requirements and an increase in shares for its equity incentive plan.
NASDAQ
SBUX
Starbucks CORPStarbucks Corporation announced its 2026 Annual Meeting of Shareholders, detailing proposals for director elections, executive compensation, auditor ratification, and several shareholder-initiated governance and social policy matters.
NASDAQ
Mitek Systems announces its 2026 Annual Meeting of Stockholders to vote on director elections, auditor ratification, executive compensation, and amendments to its Employee Stock Purchase Plan and 2020 Incentive Plan.
NASDAQ
SBUX
Starbucks CORPStarbucks reports progress on its 'Back to Starbucks' strategy in fiscal year 2025, achieving positive global comparable sales in Q4 for the first time in seven quarters, despite overall operating margin contraction and EPS decline.
NASDAQ
TruGolf Holdings, Inc. calls for its Annual Meeting to vote on key proposals including redomestication to Nevada, a new equity incentive plan, and a significant increase in authorized shares to facilitate future growth and financing.
NASDAQ
Outlook Therapeutics, Inc. has filed a definitive proxy statement with the SEC, signaling upcoming shareholder matters.
NASDAQ
Outlook Therapeutics, Inc. announces its 2026 Annual Meeting of Stockholders to be held on March 10, 2026, to vote on director elections, auditor ratification, and executive compensation.
HOLX
Hologic INCHologic, Inc. filed a definitive additional proxy statement to address stockholder lawsuits regarding its merger disclosures and announced a voluntary recall of its Brevera Breast Biopsy System needles.
Iterum Therapeutics plc reminds shareholders to cast their votes for the upcoming Extraordinary General Meeting by February 17, 2026, with the board and ISS recommending 'FOR' all four proposals.
NASDAQ
FFIV
F5, INCF5, Inc. has announced its Fiscal Year 2025 Annual Meeting of Shareholders for March 12, 2026, outlining key proposals including director elections, an incentive plan, executive compensation, and auditor ratification.
NASDAQ
FFIV
F5, INCF5, Inc. announces its Fiscal Year 2026 Annual Shareholders Meeting, highlighting an exceptional Fiscal Year 2025 with significant revenue growth and robust corporate governance updates.